International Cardio Corp. has started the first-in-human trial of its high-intensity focused ultrasound system for patients with peripheral vascular disease. The system treats vulnerable and occlusive plaques in peripheral arteries.
International Cardio begins first human use of ultrasound in PVD
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.